Quantification of changes in electroencephalographic power spectra in a patient with Budd-Chiari-syndrome after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS)
- PMID: 15918545
- DOI: 10.1007/s11011-005-2471-4
Quantification of changes in electroencephalographic power spectra in a patient with Budd-Chiari-syndrome after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS)
Abstract
We examined a 41-year-old female with a subacute Budd-Chiari Syndrome (BCS) before and after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS) by means of digital electroencephalography (EEG). After TIPSS implantation hepatic decompression had been achieved and the liver function as well as the clinical status improved daily. Simultaneously, the digital EEG showed a decrease in the power of the theta band and an increase in the physiological alpha frequency band. The theta/alpha ratio decreased after TIPSS, despite an elevated arterial ammonia level. The patient had a well-preserved liver parenchyma before the occurrence of the BCS. After portal decompression by TIPSS, the liver function normalized and the liver resumed efficient synthesis and parts of its detoxification task. This regeneration capacity was documented by a rise in cholinesterase after TIPSS. After temporary substitution of albumin the serum albumin concentration returned to normal. Thus, some neurotoxic substances with high albumin-binding capacity may not be absorbed by the central nervous system (CNS). Furthermore, it appears likely that the length of time the brain is exposed to neurotoxic substances plays a role in the clinical and electroencephalographic changes. Compared to the conventional EEG the theta/alpha ratio reflected better metabolically conditioned electroencephalographic changes after TIPSS.
Similar articles
-
Quantification of the electroencephalographic theta/alpha ratio for the assessment of portal-systemic encephalopathy following implantation of transjugular intrahepatic portosystemic stent shunt (TIPSS).Metab Brain Dis. 2002 Mar;17(1):19-28. doi: 10.1023/a:1014048229754. Metab Brain Dis. 2002. PMID: 11893005 Clinical Trial.
-
Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome.Am J Gastroenterol. 1997 Dec;92(12):2304-6. Am J Gastroenterol. 1997. PMID: 9399778
-
Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome.Aliment Pharmacol Ther. 2014 Apr;39(8):864-72. doi: 10.1111/apt.12668. Epub 2014 Feb 24. Aliment Pharmacol Ther. 2014. PMID: 24611957
-
[TIPSS in the Budd-Chiari syndrome with portal vein thrombosis].Dtsch Med Wochenschr. 1997 Jan 31;122(5):116-21. doi: 10.1055/s-2008-1047584. Dtsch Med Wochenschr. 1997. PMID: 9072481 Review. German.
-
Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1151-4. doi: 10.1097/01.meg.0000236874.75601.a1. Eur J Gastroenterol Hepatol. 2006. PMID: 17033433 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources